Characterization of cytomegalovirus reinfection in pregnancy using novel serologic methods

Active Project Grant Awarded Last action

Award ID
HT94252510083
Recipient
Awarding agency
Obligated
$277,274

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 87% complete
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The U.S. Defense Health Agency awarded a $277,274 Project Grant to the Centre Hospitalier Universitaire Sainte-Justine in Ottawa, Canada under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 2-year award, effective February 1, 2025 through January 31, 2027, is to conduct research characterizing cytomegalovirus (CMV) reinfection in pregnant women using novel serologic methods. As a prominent pediatric hospital and research center, the Centre Hospitalier Universitaire Sainte-Justine has extensive experience conducting complex medical and scientific investigations for U.S. federal agencies through competitive grants. This project will contribute to the program's goal of transforming healthcare for military service members, veterans, and the broader public by advancing scientific understanding and developing potential clinical applications related to CMV infection during pregnancy.

Quick answers

Who received award HT94252510083?

HT94252510083 was awarded to Centre Hospitalier Universitaire Sainte-Justine by Defense Health Agency (Department of Defense) on February 1, 2025.

How much is award HT94252510083 worth?

$277,274 has been obligated on HT94252510083.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login